Close Menu

Portugal has debuted a new cancer and neuroscience research center in Lisbon, reports the Associated Press. The facility was built by the Champalimaud Foundation, which began work four years ago. Portuguese businessman Antonio Champalimaud gave the foundation $688 million to complete the work and make the facility one of the best in the world, AP says. The foundation is now looking to recruit researchers from all over the world to work in the new center.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.